Amygdalar reactivity is associated with prefrontal cortical thickness in a large population-based sample of adolescents.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 26 10 2018
accepted: 15 04 2019
entrez: 4 5 2019
pubmed: 3 5 2019
medline: 23 2 2020
Statut: epublish

Résumé

In structural neuroimaging studies, reduced cerebral cortical thickness in orbital and ventromedial prefrontal regions is frequently interpreted as reflecting an impaired ability to downregulate neuronal activity in the amygdalae. Unfortunately, little research has been conducted in order to test this conjecture. We examine the extent to which amygdalar reactivity is associated with cortical thickness in a population-based sample of adolescents. Data were obtained from the IMAGEN study, which includes 2,223 adolescents. While undergoing functional neuroimaging, participants passively viewed video clips of a face that started from a neutral expression and progressively turned angry, or, instead, turned to a second neutral expression. Left and right amygdala ROIs were used to extract mean BOLD signal change for the angry minus neutral face contrast for all subjects. T1-weighted images were processed through the CIVET pipeline (version 2.1.0). In variable-centered analyses, local cortical thickness was regressed against amygdalar reactivity using first and second-order linear models. In a follow-up person-centered analysis, we defined a "high reactive" group of participants based on mean amygdalar BOLD signal change for the angry minus neutral face contrast. Between-group differences in cortical thickness were examined ("high reactive" versus all other participants). A significant association was revealed between the continuous measure of amygdalar reactivity and bilateral ventromedial prefrontal cortical thickness in a second-order linear model (p < 0.05, corrected). The "high reactive" group, in comparison to all other participants, possessed reduced cortical thickness in bilateral orbital and ventromedial prefrontal cortices, bilateral anterior temporal cortices, left caudal middle temporal gyrus, and the left inferior and middle frontal gyri (p < 0.05, corrected). Results are consistent with non-human primate studies, and provide empirical support for an association between reduced prefrontal cortical thickness and amygdalar reactivity. Future research will likely benefit from investigating the degree to which psychopathology qualifies relations between prefrontal cortical structure and amygdalar reactivity.

Identifiants

pubmed: 31048888
doi: 10.1371/journal.pone.0216152
pii: PONE-D-18-30471
pmc: PMC6497259
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0216152

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103644
Pays : United States
Organisme : MRF
ID : MRF_MRF-058-0004-RG-DESRI
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : L40 MH108486
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085772
Pays : United States
Organisme : Medical Research Council
ID : MR/N000390/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R00465X/1
Pays : United Kingdom
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States

Déclaration de conflit d'intérêts

Dr. Banaschewski has served as an advisor or consultant to Bristol-Myers Squibb, Desitin Arzneimittel, Eli Lilly, Medice, Novartis, Pfizer, Shire, UCB, and Vifor Pharma; he has received conference attendance support, conference support, or speaking fees from Eli Lilly, Janssen McNeil, Medice, Novartis, Shire, and UCB; and he is involved in clinical trials conducted by Eli Lilly, Novartis, and Shire; the present work is unrelated to these relationships. The other authors report no biomedical financial interests or potential conflicts of interest. The information, above, does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Dev Psychopathol. 2017 Aug;29(3):751-758
pubmed: 27297294
Psychoneuroendocrinology. 2016 Jan;63:109-18
pubmed: 26431805
Data Brief. 2015 Nov 10;5:929-38
pubmed: 26702424
Am J Psychiatry. 1999 May;156(5):675-82
pubmed: 10327898
Psychoneuroendocrinology. 2016 Aug;70:122-33
pubmed: 27236606
J Comp Neurol. 1995 Dec 25;363(4):615-641
pubmed: 8847421
Neuroimage. 2004;23 Suppl 1:S189-95
pubmed: 15501088
Neuroimage. 2009 Apr 1;45(2):614-26
pubmed: 19110061
Neuroimage. 2013 May 1;71:42-9
pubmed: 23313419
J Neurosci. 2012 Dec 12;32(50):18087-100
pubmed: 23238724
Mol Psychiatry. 2008 Sep;13(9):829, 833-57
pubmed: 18574483
IEEE Trans Med Imaging. 2002 Oct;21(10):1280-91
pubmed: 12585710
Soc Cogn Affect Neurosci. 2007 Dec;2(4):303-12
pubmed: 18985136
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9371-6
pubmed: 15967994
Neuroimage. 2014 Feb 15;87:345-55
pubmed: 24220041
Neuroimage. 2010 Nov 15;53(3):1093-102
pubmed: 20156572
IEEE Trans Med Imaging. 1998 Feb;17(1):87-97
pubmed: 9617910
J Neurobiol. 2001 Nov 15;49(3):245-53
pubmed: 11745662
Neuroimage. 2015 Jul 15;115:235-44
pubmed: 25887261
J Cogn Neurosci. 2003 Oct 1;15(7):991-1001
pubmed: 14614810
Biol Psychiatry. 2010 Jun 15;67(12):1128-36
pubmed: 20378100
Neuroimage. 2016 Jan 15;125:267-279
pubmed: 26463175
Nature. 2014 Aug 14;512(7513):185-9
pubmed: 25043041
Trends Cogn Sci. 2005 May;9(5):242-9
pubmed: 15866151
J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):1027-41.e3
pubmed: 21961777
J Neuroendocrinol. 2019 Apr;31(4):e12698
pubmed: 30776161
Neuroimage. 2007 Feb 15;34(4):1535-44
pubmed: 17188895
Biol Psychol. 2017 Mar;124:133-140
pubmed: 28185945
Dev Cogn Neurosci. 2012 Jan;2(1):36-54
pubmed: 22247751
J Neurosci. 2006 Apr 19;26(16):4415-25
pubmed: 16624961
J Neurosci. 2010 Dec 8;30(49):16673-8
pubmed: 21148006
Neuropsychopharmacology. 2019 Aug;44(9):1597-1603
pubmed: 30952157
Cereb Cortex. 2006 Aug;16(8):1087-96
pubmed: 16221928
Neuroscience. 2002;115(4):1261-79
pubmed: 12453496
Neuroimage. 1995 Jun;2(2):89-101
pubmed: 9343592
Soc Cogn Affect Neurosci. 2009 Mar;4(1):1-9
pubmed: 19015086
Neuroimage. 2005 Aug 1;27(1):210-21
pubmed: 15896981
Eur J Neurosci. 2014 Sep;40(5):2777-96
pubmed: 25123211
Neuroimage. 2009 Sep;47(3):864-71
pubmed: 19500680
Biol Psychiatry. 2009 Mar 1;65(5):367-73
pubmed: 18930182
Neuroimage. 2004 Oct;23(2):483-99
pubmed: 15488398
Psychoneuroendocrinology. 2017 Feb;76:206-217
pubmed: 27984812
J Comput Assist Tomogr. 1994 Mar-Apr;18(2):192-205
pubmed: 8126267
J Comp Neurol. 1984 Dec 20;230(4):465-96
pubmed: 6520247
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Med Image Comput Comput Assist Interv. 2006;9(Pt 2):58-66
pubmed: 17354756
Cereb Cortex. 2011 Jun;21(6):1379-88
pubmed: 21041200
Neurosci Biobehav Rev. 2012 Jan;36(1):479-501
pubmed: 21889953
Neuron. 2004 Sep 16;43(6):897-905
pubmed: 15363399
J Neurosci. 2002 Jan 1;22(1):324-37
pubmed: 11756516
Brain Res. 2003 Mar 7;965(1-2):290-4
pubmed: 12591150
Cereb Cortex. 2009 Oct;19(10):2479-84
pubmed: 19193712
Front Neuroinform. 2014 May 21;8:54
pubmed: 24904400
Neuroimage. 2001 Feb;13(2):375-80
pubmed: 11162277
Neuroimage. 2000 Sep;12(3):340-56
pubmed: 10944416
J Cogn Neurosci. 2010 Feb;22(2):248-62
pubmed: 19400679
Psychoneuroendocrinology. 2017 Dec;86:110-121
pubmed: 28946055
Neuroimage. 2007 Feb 1;34(3):905-23
pubmed: 17126037
Neuron. 2008 Sep 11;59(5):829-38
pubmed: 18786365
J Youth Adolesc. 1988 Apr;17(2):117-33
pubmed: 24277579
Brain Cogn. 2010 Feb;72(1):26-35
pubmed: 19595493
Mol Psychiatry. 2010 Dec;15(12):1128-39
pubmed: 21102431
Nature. 2002 Nov 7;420(6911):70-4
pubmed: 12422216
Neuroimage. 2005 Jan 1;24(1):163-73
pubmed: 15588607
Cereb Cortex. 2011 Jul;21(7):1667-73
pubmed: 21127016
Cereb Cortex. 2014 Nov;24(11):2941-50
pubmed: 23749874
Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10706-11
pubmed: 16024728

Auteurs

Matthew D Albaugh (MD)

Vermont Center for Children, Youth, and Families, Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States of America.

James J Hudziak (JJ)

Vermont Center for Children, Youth, and Families, Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States of America.

Catherine Orr (C)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States of America.

Philip A Spechler (PA)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States of America.

Bader Chaarani (B)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States of America.

Scott Mackey (S)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States of America.

Claude Lepage (C)

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Vladimir Fonov (V)

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Pierre Rioux (P)

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Alan C Evans (AC)

McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Tobias Banaschewski (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Arun L W Bokde (ALW)

Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.

Uli Bromberg (U)

University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Christian Büchel (C)

University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Erin Burke Quinlan (EB)

Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom.

Sylvane Desrivières (S)

Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom.

Herta Flor (H)

Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Department of Psychology, School of Social Sciences, University of Mannheim, Mannheim, Germany.

Antoine Grigis (A)

NeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.

Penny Gowland (P)

Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, United Kingdom.

Andreas Heinz (A)

Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charitéplatz 1, Berlin, Germany.

Bernd Ittermann (B)

Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany [or depending on journal requirements can be: Physikalisch-Technische Bundesanstalt (PTB), Berlin, Germany.

Jean-Luc Martinot (JL)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud, University Paris Descartes-Sorbonne Paris Cité; and Maison de Solenn, Paris, France.

Marie-Laure Paillère Martinot (MP)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry"; University Paris Sud; University Paris Descartes; Sorbonne Universités; and AP-HP, Department of Child and AdolescentPsychiatryPitié-Salpêtrière Hospital, Paris, France.

Frauke Nees (F)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Dimitri Papadopoulos Orfanos (DP)

NeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.

Tomáš Paus (T)

Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital and Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Luise Poustka (L)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, Göttingen, Germany.

Sabina Millenet (S)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Juliane H Fröhner (JH)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Michael N Smolka (MN)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Henrik Walter (H)

Charité -Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charitéplatz 1, Berlin, Germany.

Robert Whelan (R)

School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.

Gunter Schumann (G)

Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom.

Alexandra S Potter (AS)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States of America.

Hugh Garavan (H)

Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH